v3.23.3
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 168,708 $ 223,201 $ 382,517 $ 672,133
Costs and expenses:        
Cost of revenue 48,394 420,060 270,025 894,693
Research and development 2,460,123 2,885,830 8,418,779 9,622,886
Sales and marketing 774,141 1,093,640 3,074,163 3,865,322
General and administrative 1,698,380 1,931,386 5,763,811 5,983,845
Severance expense 269,109   359,419 633,444
Total costs and expenses 5,250,147 6,330,916 17,886,197 21,000,190
Loss from operations (5,081,439) (6,107,715) (17,503,680) (20,328,057)
Other (expense) income:        
Offering costs related to warrant liability     (591,670)  
Change in fair value of warrant liability 788,000   2,685,000  
Interest income 178,845 142,840 648,083 192,715
Total other income 966,845 142,840 2,741,413 192,715
Net loss $ (4,114,594) $ (5,964,875) $ (14,762,267) $ (20,135,342)
Basic loss per common share $ (0.86) $ (1.54) $ (3.3) $ (5.21)
Weighted average shares outstanding, basic 4,762,187 3,879,804 4,467,436 3,867,330
Diluted loss per common share $ (0.86) $ (1.54) $ (3.3) $ (5.21)
Weighted average shares outstanding, diluted 4,762,187 3,879,804 4,467,436 3,867,330

Source